Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8841 |
IMT1
Propanamide, N,N-dimethyl-2-[[4-(2-methylphenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-,LDC195943(IMT1) |
Others; DNA/RNA Synthesis; Mitochondrial Metabolism | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism; Others |
IMT1 (Propanamide, N,N-dimethyl-2-[[4-(2-methylphenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-) 是一种非竞争特异性人类线粒体 RNA 聚合酶(POLRMT) 抑制剂,可引起 POLRMT 的构象变化,以剂量依赖性方式阻断底物结合和转录。它可降低脱氧核苷三磷酸水平和柠檬酸循环中间体,导致细胞氨基酸水平显著消耗,有用于线粒体转录等相关疾病的研究潜力。 | |||
T0219 |
Valdecoxib
伐地考昔,代他考昔,SC 65872 |
COX | Immunology/Inflammation; Neuroscience |
Valdecoxib (SC 65872) 是可口服的高选择性 COX-2抑制剂,对 COX-2 和 COX-1 的 IC50值分别为 5 nM 和 140 μM,可用于治疗骨关节炎、类风湿性关节炎以及痛经和经期症状。 | |||
T30937 |
Cimicoxib
UR-8880,UR8880,trade name: Cimalgex |
COX | Immunology/Inflammation; Neuroscience |
Cimicoxib (UR8880) 是一种有效的、选择性的 COX-2 抑制剂,具有抗炎和镇痛活性。 | |||
T21294 |
Polmacoxib
CG-100649,帕马考昔,CG100649,CG 100649 |
COX; Carbonic Anhydrase | Immunology/Inflammation; Metabolism; Neuroscience |
Polmacoxib (CG 100649) 是一流的 NSAID 候选药物,是碳酸酐酶 (CA) 和 COX-2 的双重抑制剂。它在小鼠模型中抑制大肠腺瘤和肿瘤生长。 | |||
T11005 |
Desmethyl Celecoxib
|
COX | Immunology/Inflammation; Neuroscience |
Desmethyl Celecoxib 是一种选择性的环氧化酶 2 (COX-2) 抑制剂,IC50为 32 nM,具有抗炎活性。 | |||
T0484 |
Deracoxib
SC 46,SC 046,地拉考昔,SC 59046 |
Apoptosis; COX | Apoptosis; Immunology/Inflammation; Neuroscience |
Deracoxib (SC 46) 是非甾体、非麻醉性抗炎药。 它也是选择性 cyclooxygenase-2 抑制剂,IC50 值:70 至 150 μM,抑制 3 种骨肉瘤细胞系。 | |||
T35610 |
2,5-dimethyl Celecoxib
|
Apoptosis; Wnt/beta-catenin; Prostaglandin Receptor | Apoptosis; Cytoskeletal Signaling; GPCR/G Protein; Immunology/Inflammation; Stem Cells |
2,5-dimethyl Celecoxib 是塞来昔布衍生物和微粒体前列腺素 E 合酶 1 (mPGES-1) 的靶向抑制剂,mPGES-1 是炎症介质 PGE2 合成途径中的关键酶。 | |||
T26109 |
Robenacoxib
Onsior |
COX | Immunology/Inflammation; Neuroscience |
Robenacoxib (Onsior) 是一种对环氧化酶-2 有很强的选择性的非甾体化合物,具有抗炎活性。 | |||
T7670 |
Mavacoxib
|
COX | Immunology/Inflammation; Neuroscience |
Mavacoxib 是口服长效环氧合酶 2 选择性抑制剂,是长效的非甾体类抗炎药,用于犬退化性关节病相关的炎疼及痛症的研究。 | |||
T1780 |
Parecoxib
SC 69124,帕瑞昔布,Vorth-P,Valus-P |
COX | Immunology/Inflammation; Neuroscience |
Parecoxib (SC 69124) 是一种有效的选择性 COX-2 抑制剂,是 Valdecoxib 的前药。 | |||
T15571 |
Imrecoxib
BAP-909,艾瑞昔布 |
COX | Immunology/Inflammation; Neuroscience |
Imrecoxib (BAP-909) 是 COX1和 COX2的抑制剂,IC50值为 115 和 18 nM,具有抗炎作用。 | |||
T6574 |
Lumiracoxib
Prexige,罗美昔布,COX-189 |
COX | Immunology/Inflammation; Neuroscience |
Lumiracoxib (Prexige) 是强选择性有口服活性的 COX-2抑制剂,Ki 值为 0.06 μM。它是非选择性非甾体抗炎试剂,具有抗炎和解热活性,可用于骨关节炎和骨癌研究。 | |||
T0466 |
Celecoxib
塞来西布,塞来昔布,SC 58635 |
COX | Immunology/Inflammation; Neuroscience |
Celecoxib (SC 58635) 是一种非甾体抗炎药,是选择性的COX-2抑制剂,IC50为 40 nM。 | |||
T7596 |
Firocoxib
非罗考昔,ML 1785713 |
COX | Immunology/Inflammation; Neuroscience |
Firocoxib (ML 1785713) 是一种可口服的 COX-2选择性抑制剂,IC50为 0.13 μM。它具有抗炎作用,对 COX-2的选择性比对 COX-1 的选择性高 58 倍,IC50为 7.5 μM。 | |||
T1574 |
Etoricoxib
Arcoxia,MK-663,Tauxib,L-791456,Nucoxia,Desvenlafaxine,依托考昔 |
COX | Immunology/Inflammation; Neuroscience |
Etoricoxib (MK-663) 是一种合成的非甾体抗炎药 (NSAID),具有解热、镇痛和潜在的抗肿瘤特性。它是可口服的选择性 COX-2抑制剂,对人全血 COX-2 和 COX-1 的 IC50值分别为 1.1 和 116 μM。 | |||
T1185 |
Rofecoxib
MK 966,罗非昔布,罗非考昔,MK-0966 |
COX | Immunology/Inflammation; Neuroscience |
Rofecoxib (MK 966) 是可口服的 COX-2特异性抑制剂,具有抗炎、解热和镇痛特性以及潜在的抗肿瘤特性。在人骨肉瘤细胞和中国仓鼠卵巢细胞中,对人 COX-2 的 IC50值分别为 26 和 18 nM。 | |||
T24940 |
Vitacoxib
|
||
Vitacoxib is a selective inhibitor of COX-2. It is used as a novel nonsteroidal anti-inflammatory agent. | |||
T1574L |
Etoricoxib HCl
L-791456 monohydrochloride salt,L791456 hydrochloride,L-791456 hydrochloride,L 791456 hydrochloride,Etoricoxib hydrochloride |
||
Etoricoxib HCl is a synthetic, nonsteroidal anti-inflammatory drug. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2, resulting in inhibition of the conversion of arachidonic acid into prostaglandins. | |||
T70018 |
Apricoxib
|
||
Apricoxib, also known as Benzenesulfonamide 42(4ethoxyphenyl)4methyl1Hpyrrol1yl, is an orally bioavailable nonsteroidal anti-inflammatory agent (NSAID) with potential antiangiogenic and antineoplastic activities. Apricoxib binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), thereby inhibiting the conversion of arachidonic acid into prostaglandins. Apricoxib-mediated inhibition of COX-2 may induce tumor cell apoptosis and inhibit tumor cell proliferation and tumor angiogenesis. COX-related... | |||
T27233 |
Enflicoxib
E 6087,E6087,E-6087 |
||
E-6087 is a cyclooxygenase 2 (COX-2) inhibitor potentially for the treatment of osteoarthritis and pain. | |||
T37251 |
Celecoxib Carboxylic Acid Acyl-β-D-Glucuronide
|
||
Celecoxib carboxylic acid acyl-β-D-glucuronide is a phase II metabolite of celecoxib . Celecoxib is an anti-inflammatory compound from the diaryl heterocycle class that selectively inhibits cyclooxygenase-2 (COX-2; IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). Celecoxib carboxylic acid acyl-β-D-glucuronide is a minor metabolite, accounting for 2% of the administered dose in human urine and rat bile. | |||
T68571 |
Lefucoxib
|
||
Lefucoxib is a cyclooxygenase-2 (COX-2) inhibitor. | |||
T1780L |
Parecoxib sodium
SC 69124A,SC-69124A,帕瑞昔布钠,SC69124A,Dynastat |
||
Parecoxib is a cyclooxygenase-2 inhibitor used for the short-term treatment of postoperative pain in adults. Parecoxib is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib and r | |||
T15630 |
Tilmacoxib
RWJ57504,JTP19605,替马考昔,JTE522 |
COX | Immunology/Inflammation; Neuroscience |
Tilmacoxib is a highly selective, time-dependent, and irreversible inhibitor of human COX-2 ( IC50: 85 nM in an enzyme assay). | |||
T36187 |
Celecoxib Carboxylic Acid
|
||
Celecoxib carboxylic acid is an inactive metabolite of the COX-2 inhibitor celecoxib .1,2It is formed from celecoxib primarily by the cytochrome P450 (CYP) isoform CYP2C9. 1.Liu, H., Huang, X., Shen, J., et al.Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: Molecular docking and 3D QSAR analysesJ. Med. Chem.45(22)4816-4827(2002) 2.Kim, S.-H., Kim, D.-H., Byeon, J.-Y., et al.Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecox... | |||
T28541 |
Ritipenem Acoxil
Ritipenem acetoxymethyl ester,RIPM-AC |
||
Ritipenem Acoxil is an antibiotics. | |||
T70154 |
1-Hydroxyvaldecoxib
|
||
1-Hydroxyvaldecoxib is a COX-2 inhibitor. | |||
T83327 |
4'-Aarboxylic acid imrecoxib
|
||
4'-羧基酸imrecoxib是Imrecoxib的代谢产物,后者为选择性COX-II抑制剂。 | |||
T11246 |
Etoricoxib-d4
MK-0663 D4,依托考昔 D4,L-791456 D4,Etoricoxib D4 |
Others | Others |
Etoricoxib D4 is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood.Etoricoxib D4 is a deuterium labeled Etoricoxib. | |||
T39627 |
Ocarocoxib
|
||
Ocarocoxib, a potent COX- 2 (cyclooxygenase- 2) inhibitor, is a non-steroidal anti-inflammatory for veterinary use. |